Top Markets
#1 Siren Siren +33.28%
#2 Wiki Cat Wiki Cat +24.73%
#3 TRIA TRIA +20.33%
#4 Ribbita by Virtuals Ribbita by Virtuals +17.28%
#5 PulseChain PulseChain +16.92%
#6 Bitway Bitway +14.90%
#7 Nockchain Nockchain +14.88%
#8 KUB Coin KUB Coin +14.59%
#9 Velvet Velvet +14.59%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +14.56%
Coin of the day
Siren Siren
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Classement en actions #31257
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Prix de l'action
$0.39
Capitalisation boursière
$13.79M
Changement (1 jour)
-13.53%
Changement (1 an)
-68.80%
Pays
IL
Échange NeuroSense Therapeutics Ltd. (NRSN)

Catégorie

Healthcare
Ratio P/B pour NeuroSense Therapeutics Ltd. (NRSN)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de NeuroSense Therapeutics Ltd., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour NeuroSense Therapeutics Ltd. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE